Incannex Healthcare IXHL
NASDAQ IXHL
$3.21 -0.04 (-1.23%)
At close: Oct 2, 2026 · 4:00 PM EDT

Incannex Healthcare (IXHL) Return on Sales [ROS] (2024 - 2025)

Updated

Incannex Healthcare's Return on Sales [ROS] was -27661.63% in fiscal Q4 2025 (quarter ended Jun 30, 2025).

Analysis

Incannex Healthcare (IXHL) Return on Sales [ROS] (2024 - 2025) Analysis & Trends

  • Return on Sales [ROS] shows a five-year change of -27338.24 percentage points (FY2020 to FY2025).
  • In earlier fiscal years, Return on Sales [ROS] was -250341.67% in FY2024 and -651.38% in FY2021 (-327.99 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Incannex Healthcare 40.27 Mn 40.27 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -27,661.63%
Dec 31, 2024 -41,700.00%
Sep 30, 2024 -8,451.35%
API Access

Incannex Healthcare Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=IXHL&period=max&api_key=YOUR_API_KEY